Does ENZALUTAMIDE Cause Bladder cancer? 48 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 48 reports of Bladder cancer have been filed in association with ENZALUTAMIDE (Xtandi). This represents 0.1% of all adverse event reports for ENZALUTAMIDE.
48
Reports of Bladder cancer with ENZALUTAMIDE
0.1%
of all ENZALUTAMIDE reports
12
Deaths
15
Hospitalizations
How Dangerous Is Bladder cancer From ENZALUTAMIDE?
Of the 48 reports, 12 (25.0%) resulted in death, 15 (31.3%) required hospitalization, and 1 (2.1%) were considered life-threatening.
Is Bladder cancer Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ENZALUTAMIDE. However, 48 reports have been filed with the FAERS database.
What Other Side Effects Does ENZALUTAMIDE Cause?
Fatigue (8,891)
Death (6,680)
Malignant neoplasm progression (4,696)
Prostatic specific antigen increased (3,731)
Asthenia (3,589)
Drug ineffective (3,468)
Hot flush (3,144)
Decreased appetite (3,069)
Nausea (2,898)
Dizziness (2,776)
What Other Drugs Cause Bladder cancer?
RANITIDINE (41,984)
PIOGLITAZONE (7,295)
METFORMIN\PIOGLITAZONE (278)
ADALIMUMAB (268)
ETANERCEPT (225)
METHOTREXATE (179)
INFLIXIMAB (165)
APIXABAN (159)
VALSARTAN (144)
LENALIDOMIDE (120)
Which ENZALUTAMIDE Alternatives Have Lower Bladder cancer Risk?
ENZALUTAMIDE vs EPCORITAMAB
ENZALUTAMIDE vs EPCORITAMAB-BYSP
ENZALUTAMIDE vs EPERISONE
ENZALUTAMIDE vs EPHEDRINE
ENZALUTAMIDE vs EPINASTINE